Susan Bartlett, MA | |
850 Bolton Rd # U-85, Storrs Mansfield, CT 06269-9020 | |
(860) 486-2629 | |
(860) 486-5422 |
Full Name | Susan Bartlett |
---|---|
Gender | Female |
Speciality | Audiologist |
Location | 850 Bolton Rd # U-85, Storrs Mansfield, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114923638 | NPI | - | NPPES |
004070496 | Medicaid | CT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
231H00000X | Audiologist | 000626 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Susan Bartlett, MA 65 Kane St, Provider Enrollment-ellie Atkins, West Hartford, CT 06119-2110 Ph: (860) 523-6421 | Susan Bartlett, MA 850 Bolton Rd # U-85, Storrs Mansfield, CT 06269-9020 Ph: (860) 486-2629 |
News Archive
Middle-aged women with a history of preeclampsia have a greater risk of stroke, and aspirin may be able to reduce the risk, according to a new study led by researchers at Columbia University Vagelos College of Physicians & Surgeons.
Rhesus monkey babies born to mothers who had the flu while pregnant had smaller brains and showed other brain changes similar to those observed in human patients with schizophrenia, a study at the University of Wisconsin-Madison in collaboration with the University of North Carolina at Chapel Hill has found.
For the tens of thousands of individual insurance agents nationwide, the idea of a health system overhaul hits close to home – and work. The changes currently under consideration could radically alter how they do business. For example, there could be requirements that all individuals have coverage, that employers provide insurance for their workers and that insurers cover anyone - regardless of preexisting conditions. In addition, there could be a government-run public plan that might compete with insurance companies.
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced results from a pre-clinical study showing that calcipotriene 0.005% and betamethasone dipropionate 0.064%, when formulated with NexACT®, results in a topical treatment which shows bioequivalecy in efficacy to Talconex®, one of the leading topical treatments marketed for patients with mild to moderate psoriasis.
A new study to assess the effects of U.S.. Food and Drug Administration (FDA) regulations and guidance, intended to encourage greater inclusion of women and minorities in clinical drug trials, has shown appropriate levels of female participation based on the estimated sex ratio of people affected by a particular disease.
› Verified 9 days ago
Dr. Terry O'neill Yanaway, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 850 Bolton Rd, Unit 1085, Storrs Mansfield, CT 06269 Phone: 860-486-2629 Fax: 860-486-4948 |